United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2012_register
executive
2012-06-14
article
Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction
Notices
D09002ee1bdcb8a7c
D09002ee1bdcb8ae4
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 31, 2012 (77 FR 32124). The document announced the availability of a guidance for industry entitled ``Irritable Bowel Syndrome--Clinical Evaluation of Drugs for Treatment.'' The document was published with an incorrect docket number. This document corrects that error.
77 FR 35689
https://www.govinfo.gov/app/details/FR-2012-06-14/2012-14485
2012-14485
fr14jn12-47
4160-01-P
Docket No. FDA-2010-D-0146
https://www.govinfo.gov/app/details/FR-2012-06-14/2012-14485
https://www.govinfo.gov/content/pkg/FR-2012-06-14/html/2012-14485.htm
https://www.govinfo.gov/content/pkg/FR-2012-06-14/pdf/2012-14485.pdf
1 p.
35689
35689
77 FR 35689
Guidance for Industry on Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment; Availability; Correction; Federal Register Vol. 77, Issue
NOTICE
2012-14485
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. FDA-2010-D-0146
4160-01-P
2012-14485
Notice; correction.
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 31, 2012 (77 FR 32124). The document announced the availability of a guidance for industry entitled ``Irritable Bowel Syndrome--Clinical Evaluation of Drugs for Treatment.'' The document was published with an incorrect docket number. This document corrects that error.
Joyce Strong, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.
Guidance for Industry; Availability:
Irritable Bowel SyndromeClinical Evaluation of Drugs for Treatment; Availability; Correction
,
Federal Register
Vol. 77, no. 115
Office of the Federal Register, National Archives and Records Administration
2012-06-14
continuing
daily
deposited
born digital
199 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2012-06-14
P0b002ee18295c0b4
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr14jn12
https://www.govinfo.gov/app/details/FR-2012-06-14
https://www.govinfo.gov/content/pkg/FR-2012-06-14/pdf/FR-2012-06-14.pdf
https://www.govinfo.gov/content/pkg/FR-2012-06-14/xml/FR-2012-06-14.xml
fdlp
35617
35806
DGPO
2012-06-14
2023-04-30
FR-2012-06-14
machine generated
eng
FR
FR-2012-06-14
77
115